1 |
Adams RA, Bauer J, Flick MJ, Sikorski SL, Nuriel T, Lassmann H, Degen JL, Akassoglou K. The fibrin-derived gamma 377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med. 2007 ; 204 : 571-582.
DOI
ScienceOn
|
2 |
Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariëns RA. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism : effects on fibrin structure and function. Circulation. 2003 ; 107 : 2326-2330.
DOI
ScienceOn
|
3 |
Wright AF, Carothers AD, Pirastu M. Population choice in mapping genes for complex diseases. Nat Genet. 1999 ; 23 : 397-404.
DOI
ScienceOn
|
4 |
Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001 ; 409 : 928-933.
DOI
ScienceOn
|
5 |
Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet. 2001 ; 27 : 234-236.
DOI
ScienceOn
|
6 |
Howard G, Anderson R, Sorlie P, Andrews V, Backlund E, Burke GL. Ethnic differences in stroke mortality between non- Hispanic whites, Hispanic whites, and blacks. The National Longitudinal Mortality Study. Stroke. 1994 ; 25 : 2120-2125.
DOI
ScienceOn
|
7 |
Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol. 1990 ; 131 : 579-588.
|
8 |
Bogousslavsky J, Kaste M, Skyhoj Olsen T, Hacke W, Orgogozo JM. Risk Factors and Stroke Prevention. European Stroke Initiative(EUSI). Cerebrovasc Dis. 2000 ; 10 Suppl 3 : 12-21.
|
9 |
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R ; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality : a metaanalysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 : 360 : 1903-1913.
DOI
|
10 |
Whisnant JP. Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Neurology. 1996 ; 46 : 301-307.
DOI
|
11 |
권순억. 2007 ; 스타틴 계열 약물의 뇌졸중 예방효과.
|
12 |
강창원 외 6인. 개인 유전체의 단일염기 다형성 분석을 통한 발병 위험성의 예측. Busan science academy R&E 최종보고서.
|
13 |
Miller RD, Phillips MS, Jo I, Donaldson MA, Studebaker JF, Addleman N, Alfisi SV, Ankener WM, Bhatti HA, et al. High-density single-nucleotide polymorphism maps of the human genome. Genomics. 2005 ; 86 : 117-126.
DOI
ScienceOn
|
14 |
Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996 ; 273 : 1516-1517.
DOI
ScienceOn
|
15 |
Barrett JC, Fry B, Maller J, Daly MJ. Haploview : analysis and visualization of LD and haplotype maps. Bioinformatics. 2005 ; 21 : 263-265.
DOI
ScienceOn
|
16 |
Paradowski B, Maciejak A. TOAST classification of Subtypes of Ischaemic Stroke : Diagnostic and Therapeutic Procedures in Stroke. Cerebrovasc Dis. 2005 ; 20 : 319-324.
DOI
ScienceOn
|
17 |
Carter AM, Catto AJ, Grant PJ. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation. 1999 ; 99 : 2423-2426.
DOI
ScienceOn
|
18 |
Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ, Kannel WB. Secular trends in stroke incidence and mortality : the Framingham Study. Stroke. 1992 ; 23 : 1551-1555.
DOI
ScienceOn
|
19 |
황남성, 뇌졸중 중풍은 왜 무서운가 : 2006 ; 기계저널 제46권 제7호.
|
20 |
허균. 뇌졸중의 분류와 치료 : 1999 ; 노인병 제3권 제3호.
|
21 |
Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987 ; 317 : 521-526.
DOI
ScienceOn
|